Single Center Open-Label Non-Comparative Phase I Dose Finding Study Of Weekly Flavopiridol [alvocidib] In Combination With Weekly Docetaxel In Patients With Advanced Solid Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alvocidib (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 30 May 2013 Biomarkers information updated
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2005 New trial record.